Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04383951 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
A NA study of Cirrhosis, Liver and NASH - Nonalcoholic Steatohepatitis, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04383951 is a NA study of Cirrhosis, Liver and NASH - Nonalcoholic Steatohepatitis that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 40 participants, below the 241-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04383951, a NA study of Cirrhosis, Liver and NASH - Nonalcoholic Steatohepatitis, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, randomized study comparing a monitored ketogenic diet intervention using standard ketogenic diet (SKD) and standard of care (SOC) dietary recommendations for 16 weeks. Subjects enrolled in the standard of care group will receive a voucher to Weight Watchers after study completion.
Conditions Studied
Interventions
- OTHER Dietary consult for participants in the ketogenic diet arm
- OTHER Dietary consult for participants in the standard of care arm
Study Locations (1)
Indiana
- Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-08-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04383951
The ClinicalTrials.gov registry entry for NCT04383951 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (83% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cirrhosis, Liver appearing as the primary indexed condition, and to 2 interventions - of which Dietary consult for participants in the ketogenic diet arm is the first listed.
NCT04383951 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04383951 about?
NCT04383951 is a clinical study titled "Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis". This is an open-label, randomized study comparing a monitored ketogenic diet intervention using standard ketogenic diet (SKD) and standard of care (SOC) dietary recommendations for 16 weeks. Subjects enrolled in the standard of care group will receive a voucher to Weight Watchers after study complet...
What is the current status of trial NCT04383951?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-08-15. Estimated completion is 2026-12-31.
What conditions does trial NCT04383951 study?
This clinical trial studies the following conditions: Cirrhosis, Liver, NASH - Nonalcoholic Steatohepatitis.
What interventions are being tested in trial NCT04383951?
The interventions under investigation include: Dietary consult for participants in the ketogenic diet arm (OTHER), Dietary consult for participants in the standard of care arm (OTHER).
Who is sponsoring clinical trial NCT04383951?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04383951 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis, Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Molecular Mechanism of Exercise in Cirrhosis
RECRUITING · NA
-
HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis
RECRUITING · NA
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
RECRUITING · NA
-
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
RECRUITING · NA
-
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
RECRUITING · NA
-
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.